$0.400000
-0.0025-0.63%
At close: Sep 19, 5:08 PM EDT
$0.397500
-0.0025-0.63%
After Hours: 5:08 PM EDT
15 minutes delayed
Aptose Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aptose Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.43 | $-0.86 | 50.0 % |
Mar 2024 | 2024-05-14 | $-0.73 | $-0.74 | 1.35 % |
Dec 2023 | 2024-03-26 | $-1.44 | $-1.59 | 9.43 % |
Sep 2023 | 2023-11-09 | $-1.76 | $-2.05 | 14.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Aptose Biosciences (APTO) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.43, which beat the estimate of $-0.86.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.